Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin for Psoriasis Combined With Metabolic Disorders
NCT03629639Phase 4Unknown
- Sponsor
- Central South University
- Start
- Sep 2018
- Primary completion
- Sep 2020
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of metformin 1% gel in Psoriasis vulgaris (PV), metabolic disorder, sponsored by Central South University. Status: unknown.
02
Drugs
metformin 1% gel
03
Conditions
Psoriasis vulgaris (PV)metabolic disorder
Beyond the preview
Go deeper on NCT03629639.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03629639.